These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15366975)

  • 1. The general practice research database: role in pharmacovigilance.
    Wood L; Martinez C
    Drug Saf; 2004; 27(12):871-81. PubMed ID: 15366975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of diagnostic coding within the General Practice Research Database: a systematic review.
    Khan NF; Harrison SE; Rose PW
    Br J Gen Pract; 2010 Mar; 60(572):e128-36. PubMed ID: 20202356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios.
    Johansson S; Wallander MA; de Abajo FJ; García Rodríguez LA
    Drug Saf; 2010 Mar; 33(3):223-32. PubMed ID: 20158286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection.
    Postigo R; Brosch S; Slattery J; van Haren A; Dogné JM; Kurz X; Candore G; Domergue F; Arlett P
    Drug Saf; 2018 Jul; 41(7):665-675. PubMed ID: 29520645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revitalizing the General Practice Research Database: plans, challenges, and opportunities.
    Wood L; Coulson R
    Pharmacoepidemiol Drug Saf; 2001; 10(5):379-83. PubMed ID: 11802580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversial database of medical records is scrapped over security concerns.
    Limb M
    BMJ; 2016 Jul; 354():i3804. PubMed ID: 27387682
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases.
    De Wilde S; Carey IM; Bremner SA; Richards N; Hilton SR; Strachan DP; Cook DG
    Health Stat Q; 2004; (22):21-31. PubMed ID: 15704391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the general practice research database.
    Jick SS; Kaye JA; Vasilakis-Scaramozza C; Garcia Rodríguez LA; Ruigómez A; Meier CR; Schlienger RG; Black C; Jick H
    Pharmacotherapy; 2003 May; 23(5):686-9. PubMed ID: 12741446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward enhanced pharmacovigilance using patient-generated data on the internet.
    White RW; Harpaz R; Shah NH; DuMouchel W; Horvitz E
    Clin Pharmacol Ther; 2014 Aug; 96(2):239-46. PubMed ID: 24713590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance assessment of the Thai National Center for Pharmacovigilance.
    Kaewpanukrungsi W; Anantachoti P
    Int J Risk Saf Med; 2015; 27(4):225-37. PubMed ID: 26756896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptans and SCAD: An Analysis From the WHO Pharmacovigilance Database.
    Perez J; Lepelley M; Revol B; Roustit M; Cracowski JL; Khouri C
    J Am Coll Cardiol; 2021 Nov; 78(21):2129-2130. PubMed ID: 34794694
    [No Abstract]   [Full Text] [Related]  

  • 15. Good Signal Detection Practices: Evidence from IMI PROTECT.
    Wisniewski AF; Bate A; Bousquet C; Brueckner A; Candore G; Juhlin K; Macia-Martinez MA; Manlik K; Quarcoo N; Seabroke S; Slattery J; Southworth H; Thakrar B; Tregunno P; Van Holle L; Kayser M; Norén GN
    Drug Saf; 2016 Jun; 39(6):469-90. PubMed ID: 26951233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance: methods, recent developments and future perspectives.
    Härmark L; van Grootheest AC
    Eur J Clin Pharmacol; 2008 Aug; 64(8):743-52. PubMed ID: 18523760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced anaemia: a decade review of reporting to the Italian Pharmacovigilance data-base.
    Carnovale C; Brusadelli T; Casini ML; Renda F; Ruggieri S; Pimpinella G; Radice S; Clementi E
    Int J Clin Pharm; 2015 Feb; 37(1):23-6. PubMed ID: 25515616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance in perspective.
    Meyboom RH; Egberts AC; Gribnau FW; Hekster YA
    Drug Saf; 1999 Dec; 21(6):429-47. PubMed ID: 10612268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance-related topics at the level of the International Conference on Harmonisation (ICH).
    Bahri P; Tsintis P
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):377-87. PubMed ID: 15517542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.